Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1293

1.

Definitions, adjudication, and reporting of pulmonary embolism-related death in clinical studies: a systematic review.

Kraaijpoel N, Tritschler T, Guillo E, Girard P, Le Gal G.

J Thromb Haemost. 2019 Jul 13. doi: 10.1111/jth.14570. [Epub ahead of print] Review.

PMID:
31301689
2.

Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.

Klok FA, Presles E, Tromeur C, Barco S, Konstantinides SV, Sanchez O, Pernod G, Raj L, Robin P, Le Roux PY, Hoffman C, Mélac S, Bertoletti L, Girard P, Laporte S, Mismetti P, Meyer G, Leroyer C, Couturaud F; PADIS‐PE Investigators.

Res Pract Thromb Haemost. 2019 May 25;3(3):364-371. doi: 10.1002/rth2.12214. eCollection 2019 Jul.

3.

[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version].

Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Jul 4. pii: S0761-8425(19)30210-4. doi: 10.1016/j.rmr.2019.05.038. [Epub ahead of print] French. No abstract available.

PMID:
31280989
4.

Population Pharmacokinetic Analysis of Bintrafusp Alfa in Different Cancer Types.

Wilkins JJ, Vugmeyster Y, Dussault I, Girard P, Khandelwal A.

Adv Ther. 2019 Jul 5. doi: 10.1007/s12325-019-01018-0. [Epub ahead of print]

PMID:
31278692
5.

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C.

NPJ Vaccines. 2019 Jun 3;4:25. doi: 10.1038/s41541-019-0117-5. eCollection 2019.

6.

Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial.

Raj L, Robin P, Le Mao R, Presles E, Tromeur C, Sanchez O, Pernod G, Bertoletti L, Jego P, Leven F, Lemarié CA, Martin A, Planquette B, Le Roux PY, Salaun PY, Nonent M, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Leroyer C, Couturaud F; PADIS-PE Investigators.

Thromb Haemost. 2019 Jun 23. doi: 10.1055/s-0039-1692424. [Epub ahead of print]

PMID:
31230343
7.

Air pollution vs. tobacco smoking.

Girard P, Vieira T.

Eur Heart J. 2019 Jun 23. pii: ehz436. doi: 10.1093/eurheartj/ehz436. [Epub ahead of print] No abstract available.

PMID:
31230079
8.

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels.

Lambert-Niclot S, Boyd A, Fofana D, Valin N, Wirden M, Meynard JL, Palich R, Agher R, Valantin MA, Calvez V, Katlama C, Girard PM, Marcelin AG, Morand-Joubert L.

Open Forum Infect Dis. 2019 Apr 10;6(5):ofz177. doi: 10.1093/ofid/ofz177. eCollection 2019 May.

9.

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.

Kraaijpoel N, Bleker SM, Meyer G, Mahé I, Muñoz A, Bertoletti L, Bartels-Rutten A, Beyer-Westendorf J, Porreca E, Boulon C, van Es N, Iosub DI, Couturaud F, Biosca M, Lerede T, Lacroix P, Maraveyas A, Aggarwal A, Girard P, Büller HR, Di Nisio M; UPE investigators.

J Clin Oncol. 2019 Jul 10;37(20):1713-1720. doi: 10.1200/JCO.18.01977. Epub 2019 May 22.

PMID:
31116676
10.

Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.

Januel E, Godin O, Moulignier A, Lescure FX, Savatovsky J, Lamirel C, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, Assoumou L; Microvascular Brain Retina And Kidney (MicroBREAK) Study Group.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):547-551. doi: 10.1097/QAI.0000000000002084.

PMID:
31107300
11.

Time-Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma.

Wilkins JJ, Brockhaus B, Dai H, Vugmeyster Y, White JT, Brar S, Bello CL, Neuteboom B, Wade JR, Girard P, Khandelwal A.

CPT Pharmacometrics Syst Pharmacol. 2019 Apr 13. doi: 10.1002/psp4.12406. [Epub ahead of print]

12.

Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).

Garay OU, Nishimwe ML, Bousmah MA, Janah A, Girard PM, Chêne G, Moinot L, Sagaon-Teyssier L, Meynard JL, Spire B, Boyer S.

Pharmacoecon Open. 2019 Apr 9. doi: 10.1007/s41669-019-0130-7. [Epub ahead of print]

13.

In vivo localization of cortical areas using a 3D computerized atlas of the marmoset brain.

Risser L, Sadoun A, Mescam M, Strelnikov K, Lebreton S, Boucher S, Girard P, Vayssière N, Rosa MGP, Fonta C.

Brain Struct Funct. 2019 Jun;224(5):1957-1969. doi: 10.1007/s00429-019-01869-x. Epub 2019 Apr 8.

PMID:
30963231
14.

Use of comprehensive geriatric assessment (CGA) to define frailty in geriatric oncology: Searching for the best threshold. Cross-sectional study of 418 old patients with cancer evaluated in the geriatric frailty clinic (G.F.C.) of Toulouse (France).

Bréchemier D, Sourdet S, Girard P, Steinmeyer Z, Mourey L, Gérard S, Balardy L.

J Geriatr Oncol. 2019 Apr 4. pii: S1879-4068(18)30471-5. doi: 10.1016/j.jgo.2019.03.011. [Epub ahead of print]

PMID:
30956134
15.

Acetaminophen Safety: Risk of Mortality and Cardiovascular Events in Nursing Home Residents, a Prospective Study.

Girard P, Sourdet S, Cantet C, de Souto Barreto P, Rolland Y.

J Am Geriatr Soc. 2019 Jun;67(6):1240-1247. doi: 10.1111/jgs.15861. Epub 2019 Mar 26.

PMID:
30912588
16.

γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activation.

Chevalier MF, Bhatnagar N, Didier C, Lopez-Gonzalez M, Pavie J, Bollens D, Duvivier C, Collias L, Jung C, Scott-Algara D, Girard PM, Weiss L; ANRS EP56 group.

AIDS. 2019 Jul 1;33(8):1283-1292. doi: 10.1097/QAD.0000000000002196.

PMID:
30870199
17.

[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version].

Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Feb;36(2):249-283. doi: 10.1016/j.rmr.2019.01.003. Epub 2019 Feb 22. French. No abstract available.

PMID:
30799126
18.

Molecular epidemiology of ESBL-producing E. coli and K. pneumoniae: establishing virulence clusters.

Surgers L, Boersma P, Girard PM, Homor A, Geneste D, Arlet G, Decré D, Boyd A.

Infect Drug Resist. 2018 Dec 31;12:119-127. doi: 10.2147/IDR.S179134. eCollection 2019.

19.

Chlamydia trachomatis screening in urine among asymptomatic men attending an STI clinic in Paris: a cross-sectional study.

Rondeau P, Valin N, Decré D, Girard PM, Lacombe K, Surgers L.

BMC Infect Dis. 2019 Jan 8;19(1):31. doi: 10.1186/s12879-018-3595-6.

20.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D; “PADIS-DVT” investigators.

Haematologica. 2019 Jul;104(7):1493-1501. doi: 10.3324/haematol.2018.210971. Epub 2019 Jan 3.

21.

Thromboprophylaxis after Hospitalization for Medical Illness.

Girard P, Le Gal G.

N Engl J Med. 2018 Dec 6;379(23):2279. doi: 10.1056/NEJMc1813803. No abstract available.

PMID:
30592396
22.

Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.

Lemoine M, Assoumou L, De Wit S, Girard PM, Valantin MA, Katlama C, Necsoi C, Campa P, Huefner AD, Schulze Zur Wiesch J, Rougier H, Bastard JP, Stocker H, Mauss S, Serfaty L, Ratziu V, Menu Y, Schlue J, Behrens G, Bedossa P, Capeau J, Ingiliz P, Costagliola D; ANRS-ECHAM Group.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):e86-e94. doi: 10.1097/QAI.0000000000001936.

PMID:
30570529
23.

Pre-eclampsia Educational Tool Impact on Knowledge, Anxiety, and Satisfaction in Pregnant Women: A Randomized Trial.

Gingras-Charland ME, Côté AM, Girard P, Grenier A, Pasquier JC, Sauvé N.

J Obstet Gynaecol Can. 2019 Jul;41(7):960-970. doi: 10.1016/j.jogc.2018.10.003. Epub 2018 Dec 15.

PMID:
30559087
24.

Analgesic and anti-edemic properties of etifoxine in models of inflammatory sensitization.

Gazzo G, Girard P, Kamoun N, Verleye M, Poisbeau P.

Eur J Pharmacol. 2019 Jan 15;843:316-322. doi: 10.1016/j.ejphar.2018.12.018. Epub 2018 Dec 12.

PMID:
30552900
25.

Toward a global health approach: lessons from the HIV and Ebola epidemics.

Raguin G, Girard PM.

Global Health. 2018 Nov 22;14(1):114. doi: 10.1186/s12992-018-0435-9.

26.

Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection.

Malagnino V, Bottero J, Miailhes P, Lascoux-Combe C, Girard PM, Zoulim F, Lacombe K, Boyd A.

J Med Virol. 2019 Apr;91(4):630-641. doi: 10.1002/jmv.25360. Epub 2018 Dec 3.

PMID:
30431661
27.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.

Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team.

Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Erratum in: Lancet. 2018 Nov 28;:.

PMID:
30420123
28.

Key periods of cognitive decline in a nonhuman primate model of cognitive aging, the common marmoset (Callithrix jacchus).

Sadoun A, Rosito M, Fonta C, Girard P.

Neurobiol Aging. 2019 Feb;74:1-14. doi: 10.1016/j.neurobiolaging.2018.10.003. Epub 2018 Oct 11.

PMID:
30391909
29.

Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae.

Surgers L, Boyd A, Girard PM, Arlet G, Decré D.

Int J Med Microbiol. 2019 Jan;309(1):13-18. doi: 10.1016/j.ijmm.2018.10.008. Epub 2018 Oct 24.

30.

Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign.

Boyd A, Gozlan J, Carrat F, Rougier H, Girard PM, Lacombe K, Bottero J.

Epidemiol Infect. 2018 Sep 28:1-8. doi: 10.1017/S0950268818002650. [Epub ahead of print]

31.

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.

Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz PE, Revel MP, Westeel V, Dixmier A, Tredaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria JC, Friard S, Stern JB, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani JM, Alifano M, Chatellier G, Girard P.

Eur Respir J. 2018 Oct 4;52(4). pii: 1801220. doi: 10.1183/13993003.01220-2018. Print 2018 Oct.

PMID:
30262574
32.

Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure.

Commowick O, Istace A, Kain M, Laurent B, Leray F, Simon M, Pop SC, Girard P, Améli R, Ferré JC, Kerbrat A, Tourdias T, Cervenansky F, Glatard T, Beaumont J, Doyle S, Forbes F, Knight J, Khademi A, Mahbod A, Wang C, McKinley R, Wagner F, Muschelli J, Sweeney E, Roura E, Lladó X, Santos MM, Santos WP, Silva-Filho AG, Tomas-Fernandez X, Urien H, Bloch I, Valverde S, Cabezas M, Vera-Olmos FJ, Malpica N, Guttmann C, Vukusic S, Edan G, Dojat M, Styner M, Warfield SK, Cotton F, Barillot C.

Sci Rep. 2018 Sep 12;8(1):13650. doi: 10.1038/s41598-018-31911-7.

33.

Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads.

Boukli N, Boyd A, Collot M, Meynard JL, Girard PM, Morand-Joubert L.

J Antimicrob Chemother. 2018 Nov 1;73(11):3129-3136. doi: 10.1093/jac/dky316.

PMID:
30137336
34.

Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases.

Meneveau N, Guillon B, Planquette B, Piton G, Kimmoun A, Gaide-Chevronnay L, Aissaoui N, Neuschwander A, Zogheib E, Dupont H, Pili-Floury S, Ecarnot F, Schiele F, Deye N, de Prost N, Favory R, Girard P, Cristinar M, Ferré A, Meyer G, Capellier G, Sanchez O.

Eur Heart J. 2018 Dec 14;39(47):4196-4204. doi: 10.1093/eurheartj/ehy464.

PMID:
30137303
35.

Difference Between Persistent Aneurysm, Regressed Aneurysm, and Coronary Dilation in Kawasaki Disease: An Optical Coherence Tomography Study.

Dionne A, Ibrahim R, Gebhard C, Benovoy M, Leye M, Déry J, Lapierre C, Girard P, Fournier A, Dahdah N.

Can J Cardiol. 2018 Sep;34(9):1120-1128. doi: 10.1016/j.cjca.2018.05.021. Epub 2018 Jun 1.

PMID:
30093299
36.

Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa.

Fofana DB, d'Almeida M, Lambert-Niclot S, Peytavin G, Girard PM, Lafia B, Zohoun-Guidigbi L, Keke RK, Soulie C, Marcelin AG, Morand-Joubert L.

J Antimicrob Chemother. 2018 Nov 1;73(11):3143-3147. doi: 10.1093/jac/dky300.

PMID:
30060186
37.

Oncological results of full thoracoscopic major pulmonary resections for clinical Stage I non-small-cell lung cancer.

Lutz JA, Seguin-Givelet A, Grigoroiu M, Brian E, Girard P, Gossot D.

Eur J Cardiothorac Surg. 2019 Feb 1;55(2):263-270. doi: 10.1093/ejcts/ezy245.

PMID:
30052990
38.

Extensive septic myonecrosis related to compartment syndrome: is the upper extremity salvage achievable in precarious setting?

Girard P, Hassan-Farah I, Bich CS, Charpail C, Rigal S, Mathieu L.

Med Sante Trop. 2018 May 1;28(2):206-211. doi: 10.1684/mst.2018.0801.

39.

Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens.

Potard V, Goujard C, Valantin MA, Lacombe JM, Lahoulou R, Chéret A, Girard PM, Costagliola D; French Hospital Database on HIV (FHDH - ANRS CO4).

BMC Infect Dis. 2018 Jul 11;18(1):326. doi: 10.1186/s12879-018-3231-5.

40.

Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.

Le Saux O, Bourmaud A, Rioufol C, Colomban O, Guitton J, Schwiertz V, Regnier V, You B, Ranchon F, Maraval-Gaget R, Girard P, Chauvin F, Freyer G, Tod M, Henin E, Trillet-Lenoir V.

Cancer Chemother Pharmacol. 2018 Aug;82(2):319-327. doi: 10.1007/s00280-018-3612-x. Epub 2018 Jun 15.

PMID:
29948022
41.

Endobronchial treatment of peripheral tumors: ongoing development and perspectives.

Vieira T, Stern JB, Girard P, Caliandro R.

J Thorac Dis. 2018 Apr;10(Suppl 10):S1163-S1167. doi: 10.21037/jtd.2018.01.86.

42.

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.

Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, Valantin MA, Flandre P, Izopet J, Moinot L, Bouteloup V, Calvez V, Katlama C, Girard PM, Morand-Joubert L.

Clin Infect Dis. 2018 Nov 28;67(12):1883-1889. doi: 10.1093/cid/ciy382.

PMID:
29767684
43.

Differential correlations between changes to glutathione redox state, protein ubiquitination, and stress-inducible HSPA chaperone expression after different types of oxidative stress.

Girard PM, Peynot N, Lelièvre JM.

Cell Stress Chaperones. 2018 Sep;23(5):985-1002. doi: 10.1007/s12192-018-0909-y. Epub 2018 May 12.

44.

Boutiques: a flexible framework to integrate command-line applications in computing platforms.

Glatard T, Kiar G, Aumentado-Armstrong T, Beck N, Bellec P, Bernard R, Bonnet A, Brown ST, Camarasu-Pop S, Cervenansky F, Das S, Ferreira da Silva R, Flandin G, Girard P, Gorgolewski KJ, Guttmann CRG, Hayot-Sasson V, Quirion PO, Rioux P, Rousseau MÉ, Evans AC.

Gigascience. 2018 May 1;7(5). doi: 10.1093/gigascience/giy016.

45.

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).

Meynard JL, Moinot L, Landman R, Morand-Joubert L, Besseghir A, Kolta S, Spire B, Todesco E, Bouchaud O, Fagard C, Chene G, Girard PM; ANRS 140 DREAM Study Group.

J Antimicrob Chemother. 2018 Jun 1;73(6):1672-1676. doi: 10.1093/jac/dky055.

PMID:
29584910
46.

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology.

Terranova N, Girard P, Ioannou K, Klinkhardt U, Munafo A.

CPT Pharmacometrics Syst Pharmacol. 2018 Apr;7(4):228-236. doi: 10.1002/psp4.12284. Epub 2018 Feb 21.

47.

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.

Llibre JM, Hung CC, Brinson C, Castelli F, Girard PM, Kahl LP, Blair EA, Angelis K, Wynne B, Vandermeulen K, Underwood M, Smith K, Gartland M, Aboud M.

Lancet. 2018 Mar 3;391(10123):839-849. doi: 10.1016/S0140-6736(17)33095-7. Epub 2018 Jan 6. Erratum in: Lancet. 2018 Feb 1;:.

PMID:
29310899
48.

Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.

Cez A, Brocheriou I, Lescure FX, Adam C, Girard PM, Pialoux G, Moestrup SK, Fellahi S, Bastard JP, Ronco P, Plaisier E.

Hum Pathol. 2018 Mar;73:89-101. doi: 10.1016/j.humpath.2017.12.018. Epub 2018 Jan 5.

PMID:
29309806
49.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Tromeur C, Sanchez O, Presles E, Pernod G, Bertoletti L, Jego P, Duhamel E, Provost K, Parent F, Robin P, Deloire L, Leven F, Mingant F, Bressollette L, Le Roux PY, Salaun PY, Nonent M, Pan-Petesch B, Planquette B, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Mottier D, Leroyer C, Couturaud F; PADIS-PE Investigators18.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701202. doi: 10.1183/13993003.01202-2017. Print 2018 Jan.

50.

The first MICCAI challenge on PET tumor segmentation.

Hatt M, Laurent B, Ouahabi A, Fayad H, Tan S, Li L, Lu W, Jaouen V, Tauber C, Czakon J, Drapejkowski F, Dyrka W, Camarasu-Pop S, Cervenansky F, Girard P, Glatard T, Kain M, Yao Y, Barillot C, Kirov A, Visvikis D.

Med Image Anal. 2018 Feb;44:177-195. doi: 10.1016/j.media.2017.12.007. Epub 2017 Dec 9.

PMID:
29268169

Supplemental Content

Loading ...
Support Center